Elevation of soluble CD307 (IRTA2/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma-Reference-Cited by-同舟云学术

Elevation of soluble CD307 (IRTA2/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma

Published:2006-10-19 Issue:1 Volume:21 Page:169-174
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Ise T,Nagata S,Kreitman R J,Wilson W H,Wayne A S,Stetler-Stevenson M,Bishop M R,Scheinberg D A,Rassenti L,Kipps T J,Kyle R A,Jelinek D F,Pastan I

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2404445.pdf

Reference25 articles.

1. Hatzivassiliou G, Miller I, Takizawa J, Palanisamy N, Rao PH, Iida S et al. IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. Immunity 2001; 14: 277–289.

2. Davis RS, Dennis Jr G, Odom MR, Gibson AW, Kimberly RP, Burrows PD et al. Fc receptor homologs: newest members of a remarkably diverse Fc receptor gene family. Immunol Rev 2002; 190: 123–136.

3. Davis RS, Dennis Jr G, Kubagawa H, Cooper MD . Fc receptor homologs (FcRH1-5) extend the Fc receptor family. Curr Top Microbiol Immunol 2002; 266: 85–112.

4. Guselnikov SV, Ershova SA, Mechetina LV, Najakshin AM, Volkova OY, Alabyev BY et al. A family of highly diverse human and mouse genes structurally links leukocyte FcR, gp42 and PECAM-1. Immunogenetics 2002; 54: 87–95.

5. Mechetina LV, Najakshin AM, Volkova OY, Gueslnikov SV, Faizulin RZ, Alabyev BY et al. FCRL, a novel member of the leukocyte Fc receptor family possesses unique structural features. Eur J Immunol 2002; 32: 87–96.

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Just scratching the surface: novel treatment approaches for multiple myeloma targeting cell membrane proteins;Nature Reviews Clinical Oncology;2024-07-03

2. Bispecific Antibodies for Multiple Myeloma: Recent Advancements and Strategies for Increasing Their Efficacy;Frontiers in Bioscience-Landmark;2024-06-17

3. The Scientific Rationale for Targeting Tumor‐Associated Antigens;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

4. Chimeric antigen receptor T cells targeting FcRH5 provide robust tumour-specific responses in murine xenograft models of multiple myeloma;Nature Communications;2023-06-20

5. Current Status of Novel Agents for the Treatment of B Cell Malignancies: What’s Coming Next?;Cancers;2022-12-07